Korro Bio (KRRO) Enterprise Value (2019 - 2025)
Korro Bio's Enterprise Value history spans 7 years, with the latest figure at -$75.2 million for Q4 2025.
- For the quarter ending Q4 2025, Enterprise Value rose 40.4% year-over-year to -$75.2 million, compared with a TTM value of -$75.2 million through Dec 2025, up 40.4%, and an annual FY2025 reading of -$75.2 million, up 40.4% over the prior year.
- Enterprise Value for Q4 2025 was -$75.2 million at Korro Bio, up from -$92.5 million in the prior quarter.
- The five-year high for Enterprise Value was -$36.9 million in Q4 2022, with the low at -$194.9 million in Q1 2021.
- Average Enterprise Value over 5 years is -$106.7 million, with a median of -$105.2 million recorded in 2022.
- Year-over-year, Enterprise Value soared 71.74% in 2022 and then tumbled 349.83% in 2023.
- Tracing KRRO's Enterprise Value over 5 years: stood at -$130.7 million in 2021, then soared by 71.74% to -$36.9 million in 2022, then tumbled by 349.83% to -$166.2 million in 2023, then grew by 24.11% to -$126.1 million in 2024, then surged by 40.4% to -$75.2 million in 2025.
- Per Business Quant, the three most recent readings for KRRO's Enterprise Value are -$75.2 million (Q4 2025), -$92.5 million (Q3 2025), and -$96.4 million (Q2 2025).